Background and Purpose: Spiritual health is one of the important aspects of health status that may be influenced by QOL. Researchers have shown the relationship between spiritual well-being & a person's general health, so that religion and spirituality are considered the important resources for coping with stressful life events. This study aims to identify the relationship between spiritual well-being and quality of life in hemodialysis patients. Method: In this descriptive analytical study, 72 hemodialysis patients were selected using convenience sampling method. Information was collected by Paloutzian spiritual health and quality of life questionnaires (SF36). Data were analyzed by using descriptive and analytical statistics (Pearson correlation coefficient, t-test, ANOVA). Results: In line with these findings, the quality of life of the patients (47.8) 88.47 and their spiritual health scores (21.13) 88/91, most were moderate.There was no significant relationship between spiritual well-being and QOL. But there was a significant positive correlation between spiritual existential aspect of well-being and the dimensions of fatigue (P=0.02, r=0.26), emotional health (P=0.003, r=0.34), social functioning (P=0.01, r=0.29) and general health (P=0.01, r=0.29) and social performance (P=0.01, r=0.27). Also social performance had a significant positive correlation with spiritual well-being. Conclusion: According to the results, a significant relationship was observed between some aspects of quality of life and spiritual well-being. In order to understand the factors affecting the quality of life, exploring strategies to improve it and strengthen some aspects of spiritual well-being that affect the quality of life in hemodialysis patients is emphasized.
Educating the families of patients was shown in this study to improve the QOL of the patient. The design of educational programs for nursing students must emphasize the role of the family in the care of chronic patients.
Background: Most health professions, including nursing, create a lot of stress. To alleviate and cope with stresses and strains of the job, awareness of the causes is essential. Burnout and quality of work life are among factors affecting employees' performance degradation.
Background/Objectives
Side effects of current treatments and the need for a safe treatment with higher efficiency necessitate seeking new treatment options for vitiligo. Few studies have investigated the combination of psoralen with narrowband ultraviolet B (NBUVB). In this study, we compared the efficacy and safety of psoralen and NBUVB combination (P‐NBUVB) with NBUVB alone in treatment of vitiligo.
Methods
This randomised clinical trial was carried out during 2015–2017 in dermatology clinics of Ghaem and Imam Reza hospitals, Mashhad, Iran on 40 vitiligo patients with 5–60% body involvement. The patients were randomly divided into two groups of NBUVB alone and P‐NBUVB. Both groups underwent 60 phototherapy sessions (three sessions per week), and the repigmentation rate was measured using vitiligo area severity index (VASI) score. SPSS v. 16 software and appropriate statistical tests were used to analyse the data. P < 0.05 was considered statistically significant.
Results
The mean age of patients was 33.9 ± 11.3 years. Twenty patients (50%) were females. The P‐NBUVB group showed greater VASI improvement in lower extremities (P = 0.003) and overall (P = 0.026) compared with NBUVB group. Moreover, the treatment response appeared sooner in P‐NUVB group.
Conclusion
Based on our results, we can conclude that adding psoralen to NBUVB phototherapy can result in increased efficacy. However, more studies are needed to evaluate the long‐term effects and side effects of this treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.